Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Astellas Pharma Ltd
3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH
Telephone: +44 (0)1784 419615
Fax: +44 (0)1784 419583
Medical Information Direct Line: 0800 783 5018
Medical Information e-mail: medinfo@gb.astellas.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 24/11/2011
PIL Modigraf 0.2mg & 1mg granules for oral suspension

Following a review by the Commission on Human Medicines (CHM), updated advice on the prescribing and dispensing of oral tacrolimus products has been agreed. This updated advice is that all oral tacrolimus medicines in the UK should be prescribed and dispensed by brand name only.

Further information:

MHRA press release

Letter sent to healthcare professionals

Questions and answers document


The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. This PIL is in PDF format.

View Patient Information Leaflet (0.254MB)

Are you having problems reading or printing this PDF? Visit adobe.com and download the Adobe Acrobat Reader.


More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/22721/PIL/


Black Triangle

This medicine is monitored intensively by the CHM and MHRA

Active Ingredients/Generics

 
  tacrolimus monohydrate